Skip to Main Content

Paper Details

Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer.
Nat Commun
12
2022
APOBEC, APOBEC mutational, Ba/Sq, Bladder Cancer, Patient, SBS13, Stroma-rich subtypes, TP53, TP53 mutations, UC, Urothelial Cancer, inflamed tumor, metastatic, metastatic urothelial cancer, patients, urothelial carcinoma
Author NameAffiliation
Matthew D GalskyTisch Cancer Institute, Icahn School of Medicine at Mount Sinai
David I QuinnUniversity of Southern California Norris Comprehensive Cancer Center
Benjamin G VincentLineberger Comprehensive Cancer Center, University of North Carolina
Benjamin G VincentUniversity of North Carolina
Benjamin G VincentUniversity of North Carolina
Benjamin G VincentUniversity of North Carolina
Benjamin G VincentUniversity of North Carolina
Katherine A HoadleyLineberger Comprehensive Cancer Center, University of North Carolina
Katherine A HoadleyUniversity of North Carolina
Katherine A HoadleyLineberger Comprehensive Cancer Center, University of North Carolina
Katherine A HoadleyUniversity of North Carolina
  • 1 - 11

Datasets

Release 1.2